I guess the market has come to the realisation that a market cap below $100m is totally unreasonable for this stock, which means share prices of 16 cents and lower. CXM is massively derisked operationally and only has some financing risks, which we all know debt financing shouldn't be an issue for them with offtake agreements for full production. So it's not reasonable to trade at more than 55% discount to its DFS NPV, which was based on phosphate prices in a fraction of current prices.
- Forums
- ASX - By Stock
- CXM Chart
CXM
centrex limited
Add to My Watchlist
0.00%
!
1.7¢

I guess the market has come to the realisation that a market cap...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.74M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CXM (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online